Photodynamic Therapy Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Photodynamic Therapy Market 

5.1. COVID-19 Landscape: Photodynamic Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Photodynamic Therapy Market, By Product Type

8.1. Photodynamic Therapy Market, by Product Type, 2024-2033

8.1.1. Photosensitizer Drugs

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Photodynamic Therapy Devices

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Photodynamic Therapy Market, By Light Source

9.1. Photodynamic Therapy Market, by Light Source, 2024-2033

9.1.1. Lasers

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Light Emitting Diodes (LEDs)

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Lamps

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Photodynamic Therapy Market, By Application 

10.1. Photodynamic Therapy Market, by Application, 2024-2033

10.1.1. Cancer

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Actinic Keratosis (AK)

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Psoriasis

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Acne

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Photodynamic Therapy Market, By End User 

11.1. Photodynamic Therapy Market, by End User, 2024-2033

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Cancer Treatment Centers

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Cosmetic and Dermatology Clinics

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Photodynamic Therapy Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.1.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.1.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Forecast, by End User (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End User (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.2.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.2.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Forecast, by End User (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End User (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End User (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End User (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.3.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.3.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Forecast, by End User (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End User (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End User (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End User (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.4.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.4.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Forecast, by End User (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End User (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End User (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End User (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.5.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Light Source (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End User (2021-2033)

Chapter 13. Company Profiles

13.1. Gladerma S.A.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Sun Pharmaceutical Industries Ltd.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Biofrontera

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Novartis AG

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Valeant Pharmaceuticals International, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Quest Pharmatech, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Hologic, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Lumibird (Quantel Medical)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Theralase Technologies Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Photocure ASA

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms